[Endovascular surgery and the validation of immunocorrection in patients with liver cirrhosis complicated by portal hypertension].
An analysis of results of complex clinico-immunological studies in 110 patients with liver cirrhosis complicated by portal hypertension has been made. A scheme of immunocorrective therapy with T-activin in patients with liver cirrhosis complicated by portal hypertension is substantiated and developed for performing roentgen endovascular interventions.
Karimov
Sh I
ShI
Kim
V F
VF
Iunusov
I R
IR
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D007111:Immunity, Cellular; D008103:Liver Cirrhosis / Q000150:complications / Q000276:immunology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000627:therapeutic use*; D015641:Radiography, Interventional; D013156:Splenectomy; D013949:Thymus Extracts / Q000627:therapeutic use*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Endovaskuliarnaia khirurgiia i obosnovanie immunokorrektsii u bol'nykh tsirrozom pecheni, oslozhnennym portal'noĭ gipertenzieĭ.